Skip to content

Parker Quality & Compliance

PQC Reg Watch

Sponsor this week — one slot, $75, newsletter line and this bar

Device recall

Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103

FDA recall source

Recall number
Z-0317-2027
Event id
99863
Status
Open, Classified
FDA classification
Class II
Recalling firm
Accriva Diagnostics, Inc.
Posted
Oct 30, 2026
Initiated
Sep 14, 2026
Product code
JPA
Device type
System, Multipurpose For In Vitro Coagulation Studies
Reason
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
Root cause
Process control
Quantity
28710
Code info
UDI-DI: 10711234103012, Lot(Expiration): B6JCA005(02/28/2027), C6JCA008(03/31/2027), D6JCA011(04/30/2027), K5JCA041(10/31/2026), C6JCA007(03/31/2027)
Distribution
Worldwide - US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia.
Related 510(k)s
K940401
Location
San Diego, CA